Conservative management of patients with endometrial intraepithelial neoplasia (EIN): Factors that could affect response and pregnancy rates.

References (5)

1. Işçi Bostanci E, Durmuş Y, Duru Çöteli SA, Kayikçioğlu F, Boran N. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/ endometrial cancer: Wait or treat! Turkish Journal Of Medical Sciences 2021
2. 51 (4):2066-2072. doi: 10.3906/sag-2012-207 2. Cordeiro Mitchell CN, Hunkler KF, Maher JY, Garbose RA, Gornet ME et al. Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae. Journal of Gynecology Obstetrics and Human Reproduction 2021
3. 50 (5):101930. doi: 10.1016/j.jogoh.2020.101930 3. Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL et al. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/ endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecologic Oncology 2020
4. 157 (2):348-356. doi: 10.1016/j. ygyno.2020.02.008 4. Raffone A, Travaglino A, Saccone G, Di Maio A, Mollo A et al. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecological Endocrinology 2019
5. 35 (11):932- 937. doi: 10.1080/09513590.2019.1624716